NanoViricides
NNVC
#10560
Rank
NZ$60.3 M
Marketcap
NZ$2.36
Share price
-6.99%
Change (1 day)
-18.55%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2026 (TTM): NZ-$0.77

According to NanoViricides's latest financial reports the company's current EPS (TTM) is NZ-$0.78. In 2025 the company made an earnings per share (EPS) of NZ-$1.12 an increase over its 2024 EPS that were of NZ-$1.24.

EPS history for NanoViricides from 2005 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.77-31.54%
2025NZ-$1.12-10%
2024NZ-$1.24-5.41%
2023NZ-$1.315.71%
2022NZ-$1.24-13.58%
2021NZ-$1.44-66.11%
2020NZ-$4.241.7%
2019NZ-$4.17-10.98%
2018NZ-$4.69-22.35%
2017NZ-$6.04-10.53%
2016NZ-$6.75375%
2015NZ-$1.42-85.19%
2014NZ-$9.5942.11%
2013NZ-$6.7526.67%
2012NZ-$5.33-6.25%
2011NZ-$5.6814.28%
2010NZ-$4.97100%
2009NZ-$2.49-0%
2008NZ-$2.49-33.33%
2007NZ-$3.73-0%
2006NZ-$3.734445.07%
2005NZ-$0.08203

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
NZ-$4.62 490.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$2.25-387.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.06-1,131.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.68-826.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
NZ-$2.70 245.45%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ-$2.56 227.27%๐Ÿ‡บ๐Ÿ‡ธ USA